Sagimet Biosciences Inc.

SGMT · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.5B · 16 employees
63
SEC Filings
$7.29
Close 2026-05-29
16
Employees

Business Summary

PART I Overview We are a clinical-stage biopharmaceutical company developing novel therapeutics called fatty acid synthase (FASN) inhibitors that target dysfunctional metabolic and fibrotic pathways in diseases resulting from the overproduction of the fatty acid, palmitate. Our lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), acne and select forms of cancer. Our ...

Latest Stock Quote

SGMT 2026-05-29 $7.29 O:$7.25 H:$7.355 L:$7.01 Vol:0.6M VWAP:$7.224
origin leaf: a171cc83dc1852f67c4bc4bf0b44fbbf40a1ad211c538caacfdf9e07a633b6ea

Next Earnings

Q2 FY2026 — expected 2026-08-15

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-112025-12-310001104659-26-026140EDGAR107K words
2025-03-122024-12-310001558370-25-002747EDGAR—
2024-03-252023-12-310001558370-24-003812EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001104659-25-110846EDGAR20K words
2025-08-132025-06-300001558370-25-011301EDGAR—
2025-05-082025-03-310001558370-25-006836EDGAR—
2024-11-142024-09-300001558370-24-015623EDGAR—
2024-08-142024-06-300001558370-24-012136EDGAR—
2024-05-152024-03-310001558370-24-008205EDGAR—
2023-11-132023-09-300001558370-23-018700EDGAR—
2023-08-212023-06-300001104659-23-093910EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-110001104659-26-026146EDGAR7K words
2026-02-020001104659-26-008925EDGAR—
2025-12-180001104659-25-122272EDGAR—
2025-12-170001104659-25-121819EDGAR—
2025-11-130001104659-25-110852EDGAR—
2025-10-230001104659-25-101819EDGAR—
2025-08-220001104659-25-081630EDGAR—
2025-08-140001104659-25-078752EDGAR—
2025-08-130001104659-25-077200EDGAR—
2025-06-100001104659-25-058201EDGAR—

63 total filings indexed. 42 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001400118
TickerSGMT
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.sagimet.com
Listed2023-07-14

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 27bbe2b9bb3065a106b97c4015ff087d4a9a043ec479ffdb43f1aa188bcaed34
parent: c9237db7aa279a3d504315149959a21842d7a28cec98f85f3a0afba0e586db8d
content hash: e3876e8b3f4c61bc203a219c1cb816b5e73e427837f248ea981d6fed43fcb21b
signed: 2026-06-03T12:02:33.440Z
sources: 12 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf